XML 13 R6.htm IDEA: XBRL DOCUMENT v3.26.3
STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:        
Net loss $ (48,076) $ (32,587) $ (125,335) $ (98,963)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation     813 900
Stock-based compensation expense     20,179 18,759
Amortization of premium (accretion of discount) on investments, net     690 (2,060)
Changes in operating assets and liabilities:        
Prepaid expenses and other assets     (4,490) (325)
Accounts payable and accrued other liabilities     2,114 (6,798)
Net cash used in operating activities     (106,029) (88,487)
Cash flows from investing activities:        
Acquisitions of property and equipment     (465) (485)
Purchases of investments     (143,103) (354,530)
Maturities of investments     175,000 190,000
Net cash provided by (used in) investing activities     31,432 (165,015)
Cash flows from financing activities:        
Proceeds from issuance of common stock and pre-funded warrants     60,881 244,369
Issuance costs associated with financings     (993) (2,397)
Proceeds from issuance of common stock under ESPP     679 757
Proceeds from stock option exercises     2,207 1,035
Net cash provided by financing activities     62,774 243,764
Net decrease in cash, cash equivalents and restricted cash     (11,823) (9,738)
Cash, cash equivalents and restricted cash at beginning of period     46,160 59,897
Cash, cash equivalents and restricted cash at end of period 34,337 50,159 34,337 50,159
Cash and cash equivalents 33,846 49,668 33,846 49,668
Restricted cash included in other assets 491 491 491 491
Total cash, cash equivalents and restricted cash $ 34,337 $ 50,159 $ 34,337 $ 50,159